Skip to main content
Signal8

Ahlers James M

SEC insider (Form 3/4/5 filer). CIK 0001320383. Chief Financial Officer at Cue Biopharma, Inc. (CUE). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 30, 2026. Located in BOSTON, MA.

Companies Ahlers James M has filed insider reports for

  • Cue Biopharma, Inc. (CUE): Officer, Chief Financial Officer
Ahlers James M profile photo

Ahlers James M

CIK: 0001320383

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cue Biopharma, Inc. logo
CUE

Cue Biopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Jul 30, 2026
    Award
    Direct
    25.5K shares-

1-1 of 1